Introduction of antifolics in psoriasis. A twenty-five year retrospect of antineoplastic agents in nonmalignant disease.
Presented herein is a review of the beneficial use of the folic acid antagonist, aminopterin, in the treatment of psoriasis and other dermatologic disorders.
D000328:Adult; D000630:Aminopterin / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy*; D012189:Retrospective Studies; D012214:Rheumatic Heart Disease / Q000188:drug therapy
D007166:Immunosuppressive Agents; D008466:Mechlorethamine; D000630:Aminopterin; D008727:Methotrexate